As Business of Cannabis heads into February, there is no shortage of things to talk about Canadian cannabis sector and we were lucky to have Michael Garbuz from CannaRoyalty join us this afternoon to look at the Week that was.
The conversation did not touch on the Toronto Police Services education regarding edible cannabis, but did touch on HIKU (DOJA/Tokyo Smoke), Aphria’s acquisition of Nuuvera, Canopy Ventures and CannaRoyalty’s debt-financing partnership Trichome.
The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
Event
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through...
After a broadly optimistic and reform-driven 2024, this year saw momentum beging to shift once again for the global cannabis...
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow...
There is a frustrating misimpression circulating in the cannabis community regarding rescheduling. Many headlines state that Trump is considering finishing...
The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) published a draft opinion on July 09,...
In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris...
In today’s crowded cannabis landscape, where “premium” is often used as a buzzword, The Medocann Group is setting a higher...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
